의료 데이터 수익화 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 데이터 소스별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Healthcare Data Monetization Market Summary

The global healthcare data monetization market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.1 billion in 2026 to USD 3.7 billion by 2033, at a CAGR of 8.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 51.8% in 2025. This growth is attributed to the widespread adoption of Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Hospital Information Systems (HIS), Laboratory Information Systems (LIS), and digital imaging platforms, which has resulted in an exponential increase in structured and unstructured healthcare data.

Healthcare providers and payers are increasingly leveraging these datasets to generate additional revenue through analytics services, licensing, benchmarking, and value-added insights.

Global Healthcare Data Monetization Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare data monetizationmarket report based on product type, data source, application, end use and regions.

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
• Data Subscription (patient-level / aggregate / licensed datasets)
• Insights-as-a-Service (curated analytics products)
• Models / Decision Engines (AI-enabled predictive products)
• Data Source Outlook (Revenue, USD Million, 2021 - 2033)
• Claims Data
• EHR/EMR Data
• Pharmacy Data
• Genomics Data
• Patient-Generated Health Data
• Imaging Data
• Laboratory Data
• Integrated Data Assets
• Others (Social Determinants of Health (SDoH) Data, Behavioral Data, Survey and Patient-Reported Data)
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Safety, Adherence & Health Economics and Outcomes Research (HEOR)
• Quality Improvement & Care Gap Closure
• Network & Operational Optimization
• Market Access & Commercial Strategy
• Clinical Research & Trial Enablement
• HCP & Customer Targeting
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical Companies
• Healthcare Providers
• Biotechnology Firms
• Research Institutions
• Healthcare Payers
• Medical Device Manufacturers
• Government Agencies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Data Source
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Commercialization of De-identified and Longitudinal Patient Data Assets
    • 3.2.1.2. Growing Utilization of Integrated and Multi-Modal Data Assets
    • 3.2.1.3. Growing Demand for Real-World Evidence (RWE) and HEOR Studies
    • 3.2.1.4. Expansion of Precision Medicine and Personalized Therapeutics
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Data privacy, security, and regulatory compliance concerns (HIPAA, GDPR, etc.)
    • 3.2.2.2. Challenges related to healthcare data quality, standardization, and interoperability across disparate systems
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. Healthcare Data Monetization Market: Product Type Estimates & Trend Analysis

• 4.1. Product Type Segment Dashboard
• 4.2. Product Type Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
• 4.4. Data Subscription (patient-level / aggregate / licensed datasets)
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Insights-as-a-Service (curated analytics products)
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Models/Decision Engines (AI-enabled predictive products)
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Healthcare Data Monetization Market: Data Source Estimates & Trend Analysis

• 5.1. Data Source Segment Dashboard
• 5.2. Data Source Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Data Source, 2021 to 2033 (USD Million)
• 5.4. Claims Data
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. EHR/EMR Data
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Pharmacy Data
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Genomics Data
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Patient-Generated Health Data
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Imaging Data
  • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Laboratory Data
  • 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Integrated Data Assets
  • 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.12. Others
  • 5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Healthcare Data Monetization Market: Application Estimates & Trend Analysis

• 6.1. Application Mode Dashboard
• 6.2. Application Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Safety, Adherence & Health Economics and Outcomes Research (HEOR)
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Quality Improvement & Care Gap Closure
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Network & Operational Optimization
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Market Access & Commercial Strategy
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Clinical Research & Trial Enablement
  • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. HCP & Customer Targeting
  • 6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Healthcare Data Monetization Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2025 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical Companies
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Healthcare Providers
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Biotechnology Firms
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Research Institutions
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Healthcare Payers
  • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.9. Medical Device Manufacturers
  • 7.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.10. Government Agencies
  • 7.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.11. Others
  • 7.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Healthcare Data Monetization Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market: Key Takeaways
• 8.3. North America
  • 8.3.1. North America healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamic
    • 8.3.2.2. Regulatory framework
    • 8.3.2.3. Competitive insights
    • 8.3.2.4. U.S. healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamic
    • 8.3.3.2. Regulatory framework
    • 8.3.3.3. Competitive insights
    • 8.3.3.4. Canada healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamic
    • 8.3.4.2. Regulatory framework
    • 8.3.4.3. Competitive insights
    • 8.3.4.4. Mexico healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamic
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive insights
    • 8.4.2.4. Germany healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key country dynamic
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive insights
    • 8.4.3.4. UK healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamic
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive insights
    • 8.4.4.4. France healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamic
    • 8.4.5.2. Regulatory framework
    • 8.4.5.3. Competitive insights
    • 8.4.5.4. Italy healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamic
    • 8.4.6.2. Regulatory framework
    • 8.4.6.3. Competitive insights
    • 8.4.6.4. Spain healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key country dynamic
    • 8.4.7.2. Regulatory framework
    • 8.4.7.3. Competitive insights
    • 8.4.7.4. Denmark healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key country dynamic
    • 8.4.8.2. Regulatory framework
    • 8.4.8.3. Competitive insights
    • 8.4.8.4. Sweden healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key country dynamic
    • 8.4.9.2. Regulatory framework
    • 8.4.9.3. Competitive insights
    • 8.4.9.4. Norway healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key country dynamic
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive insights
    • 8.5.2.4. Japan healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key country dynamic
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive insights
    • 8.5.3.4. China healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamic
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive insights
    • 8.5.4.4. India healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamic
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive insights
    • 8.5.5.4. South Korea healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamic
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive insights
    • 8.5.6.4. Australia healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamic
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive insights
    • 8.5.7.4. Thailand healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Healthcare Data Monetization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamic
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive insights
    • 8.6.2.4. Brazil healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamic
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive insights
    • 8.6.3.4. Argentina healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamic
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive insights
    • 8.7.2.4. South Africa healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamic
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive insights
    • 8.7.3.4. Saudi Arabia healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamic
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive insights
    • 8.7.4.4. UAE healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamic
    • 8.7.5.2. Regulatory framework
    • 8.7.5.3. Competitive insights
    • 8.7.5.4. Kuwait healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis, 2025
• 9.3. Company Categorization
• 9.4. Strategy Mapping
• 9.5. Company Profiles/Listing
  • 9.5.1. IQVIA
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. Oracle
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Optum
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Veradigm
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. Komodo Health
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. Cotiviti
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. Inovalon
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. HealthVerity
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Truveta
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. Datavant
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. Innovaccer
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product benchmarking
    • 9.5.11.4. Strategic initiatives
  • 9.5.12. COTA
    • 9.5.12.1. Overview
    • 9.5.12.2. Financial performance
    • 9.5.12.3. Product benchmarking
    • 9.5.12.4. Strategic initiatives
  • 9.5.13. Flatiron Health
    • 9.5.13.1. Overview
    • 9.5.13.2. Financial performance
    • 9.5.13.3. Product benchmarking
    • 9.5.13.4. Strategic initiatives
  • 9.5.14. Tempus AI
    • 9.5.14.1. Overview
    • 9.5.14.2. Financial performance
    • 9.5.14.3. Product benchmarking
    • 9.5.14.4. Strategic initiatives